Neurotoxicity associated with treatment of acute lymphoblastic leukemia chemotherapy and immunotherapy

P Śliwa-Tytko, A Kaczmarska, M Lejman… - International Journal of …, 2022 - mdpi.com
Immunotherapy is a milestone in the treatment of poor-prognosis pediatric acute
lymphoblastic leukemia (ALL) and is expected to improve treatment outcomes and reduce …

The battlefield of chemotherapy in pediatric cancers

L Bo, Y Wang, Y Li, JND Wurpel, Z Huang, ZS Chen - Cancers, 2023 - mdpi.com
Simple Summary The survival rate for pediatric cancers has improved significantly over the
last decades. Conventional chemotherapies play a vital role in pediatric cancer treatment …

Proactive therapeutic drug monitoring of vincristine in pediatric and adult cancer patients: current supporting evidence and future efforts

CY Wu, GT Li, CC Chu, HL Guo, WR Fang, T Li… - Archives of …, 2023 - Springer
Vincristine (VCR), an effective antitumor drug, has been utilized in several polytherapy
regimens for acute lymphoblastic leukemia, neuroblastoma and rhabdomyosarcoma …

Advancements in the impact of human microbiota and probiotics on leukemia

Y Zhang, X Zhao, J Zhang, Y Zhang, Y Wei - Frontiers in Microbiology, 2024 - frontiersin.org
The human gut microbiota is a complex ecosystem that plays a crucial role in promoting the
interaction between the body and its environment. It has been increasingly recognized that …

[HTML][HTML] Precision Medicine in Childhood Cancer: The Influence of Genetic Polymorphisms on Vincristine-Induced Peripheral Neuropathy

L Marangoni-Iglecias, S Rojo-Tolosa… - International Journal of …, 2024 - mdpi.com
Cancer is the leading cause of disease-related death among children. Vincristine (VCR), a
key component of childhood cancer treatment protocols, is associated with the risk of …

[HTML][HTML] 急性淋巴细胞白血病儿童认知功能损害的临床研究进展

覃李娇, 麦惠容 - Chinese Journal of Contemporary Pediatrics, 2023 - ncbi.nlm.nih.gov
急性淋巴细胞白血病( acute lymphoblastic leukemia, ALL) 是儿童期最常见的恶性肿瘤性疾病
。 随着临床诊治水平的不断提高, 获得完全缓解后长期生存的ALL 儿童越来越多 …

Analysis of the incidence, characteristics, and risk factors of complications during induction chemotherapy in children with high-risk neuroblastoma

J Du, X Yuan - European Journal of Pediatrics, 2024 - Springer
Patients with high-risk neuroblastoma (HR-NB) exhibit suboptimal 5-year survival rates,
leading to a widespread international preference for high-intensity chemotherapeutic …

[HTML][HTML] Prevention of vincristine-induced peripheral neuropathy by protecting the endothelial glycocalyx shedding

K Ohmura, T Kinoshita, H Tomita, H Okada… - Biochemical and …, 2024 - Elsevier
Vincristine-induced peripheral neuropathy (VIPN) adversely affects the quality of life and
treatment continuity of patients. The endothelial glycocalyx (eGCX) protects nerves from …

An induced pluripotent stem cell-based model identifies molecular targets of vincristine neurotoxicity

NW Tsai, CC Lin, TY Yeh, YA Chiu… - Disease Models & …, 2022 - journals.biologists.com
To model peripheral nerve degeneration and investigate molecular mechanisms of
neurodegeneration, we established a cell system of induced pluripotent stem cell (iPSC) …

Severe Vincristine-Induced Peripheral Neuropathic Weakness in Both Lower Limbs in an Asian Adolescent with CYP3A4 rs2740574 TT Genotype

D Zhang, J Bai - Pharmacogenomics and Personalized Medicine, 2024 - Taylor & Francis
Background Vincristine (VCR)-induced peripheral neuropathy (VIPN) is a common adverse
reaction during cancer treatment, typically characterized by numbness and paresthesias …